Brazil becomes first malaria endemic country to approve P. vivax-targeting tafenoquine
Brazil’s National Health Surveillance Agency (ANVISA) has approved GlaxoSmithKline (GSK) Brazil and Medicines for Malaria...
Read More...
Focus:
Brazil
-
![Top orphan drugs]()
The world’s top ten orphan drugs in oncology in 2018
The top ten orphan drugs in oncology accounted for approximately $54.1bn in net sales in...
Read More...
-
M&As this week: Novartis, Takeda, Dechra Pharmaceuticals
Novartis has entered an agreement to acquire Endocyte for approximately $2.1bn.
Read More...
-
Deals this week: Eisai Pharmaceutical, Abbvie, Otsuka
Eisai Pharmaceutical has signed an agreement with Eurofarma Laboratorios for the marketing and distribution of...
Read More...
-
![Masters Speciality Pharma]()
Masters Speciality Pharma: bringing high-quality drugs to emerging markets
Masters Speciality Pharma seeks to correct the side-lining of the developing world in terms of...
Read More...
-
![Sovaldi]()
Brazilian court strips Gilead of its patent for Hepatitis C drug Sovaldi
A judge from the 21st Federalist Court of Brasilia has ruled to invalidate US biopharma...
Read More...
-
![]()
Biocon and Mylan’s biosimilar receives Brazilian regulatory approval
Brazilian regulatory agency ANVISA has approved Biocon and Mylan's biosimilar Trastuzumab through their partner Libbs...
Read More...
